Table 9.

Adjusted mortality for confounders across mean pulmonary artery pressure groups in patients with a pulmonary vascular resistance >2–≤3 WU

	Adjusted for lung diseasea  n = 718		Adjusted for heart diseasea  n = 694		Adjusted for CTDa  n = 735		Adjusted for lung and heart diseasea  n = 680		Adjusted for all comorbiditiesa  n = 680
	HR (95% CI)	P-value	HR (95% CI)	P-value	HR (95% CI)	P-value	HR (95% CI)	P-value	HR (95% CI)	P-value
mPAP 21–24 mmHg	1.56 (1.13–2.15)	.007147	1.64 (1.18–2.26)	.00283	1.56 (1.14–2.13)	.00537	1.71 (1.23- 2.39)	.00151	1.75 (1.25–2.44)	.00107
mPAP ≥25 mmHg	2.12 (1.57–2.86)	.000000914	1.96 (1.44–2.67)	.0000210	2.14 (1.60–2.86)	.000000244	2.00 (1.45–2.75)	.0000236	2.05 (1.48–2.82)	.0000125

^aAdjusted for age/sex.